Skip to main content

Nasdaq Stocks

Despite A 50% Rally Haemonetics Has More Upside

5 years 11 months ago
We believe that Haemonetics stock (NYSE: HAE), best known for its blood and plasma supplies and services, is a good buying opportunity at the present time. HAE stock trades near $113 currently and it is, in fact, down 7% from its pre-Covid high of $122 in February 2020 &nd

Freeport-McMoRan Stock Rises 4.5x – Time To Exit?

5 years 11 months ago
After an eye-popping rise of more than 4.5x from its March lows of this year, at the current price of $23 per share, we believe Freeport-McMoRan stock (NYSE: FCX) is overvalued. FCX stock has rallied from $5 to $23 off its recent bottom compared to the S&P 500 which increas

Verisign Stock To Surge To Fresh Highs?

5 years 11 months ago
Despite a more than 30% rise from its low in March, at the current price of $200 per share, we believe Verisign stock (NASDAQ: VRSN) is still a good opportunity for investors. Verisign stock has risen from $151 to $200 off the recent bottom, less than the S&P which increase

Down 19% YTD, Realty Income Stock Has Growth Potential

5 years 11 months ago
Despite a 38% rise since the March 23 lows of this year, at the current price of around $60 per share we believe Realty Income stock (NYSE: O) has more to go. Realty Income, a REIT (Real Estate Investment Trust) with a portfolio of more than 6500 commercial properties, has seen

CrowdStrike (CRWD) Beats, Snowflake (SNOW) Mixed in Q3

5 years 11 months ago
Markets were tepid on this Hump Day, after fair-to-middling private-sector employment numbers from ADP ADP ahead of today’s opening bell, and an announcement mid-day that New York state is scheduled to receive 170K vaccine doses by December 15th — two weeks from yesterday. Th
Checked
11 minutes 28 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks
Subscribe to Nasdaq Stocks feed